Report Detail
Global Pertussis Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
- RnM2921230 |
- 17 April, 2023 |
- Global |
- 114 Pages |
- GIR (Global Info Research) |
- Pharma & Healthcare
Pertussis vaccine is a vaccine that protects against whooping cough. There are two main types: whole-cell vaccines and acellular vaccines. The whole-cell vaccine is about 78% effective while the acellular vaccine is 71–85% effective.
According to our (Global Info Research) latest study, the global Pertussis Vaccine market size was valued at USD 5338.1 million in 2022 and is forecast to a readjusted size of USD 6722.7 million by 2029 with a CAGR of 3.3% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global pertussis vaccine key players include Sanofi Pasteur, GSK, Mitsubishi Tanabe Pharma, Wuhan Institute of Biological Products, Walvax Biotechnology etc. Global top 2 manufacturers hold a share about 90%. Europe is the largest market, with a share over 30%, followed by North America.
This report is a detailed and comprehensive analysis for global Pertussis Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Pertussis Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (M Doses), and average selling prices (USD/Doses), 2018-2029
Global Pertussis Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (M Doses), and average selling prices (USD/Doses), 2018-2029
Global Pertussis Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (M Doses), and average selling prices (USD/Doses), 2018-2029
Global Pertussis Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (M Doses), and ASP (USD/Doses), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Pertussis Vaccine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Pertussis Vaccine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi Pasteur, GSK, Mitsubishi Tanabe Pharma, Wuhan Institute of Biological Products and Walvax Biotechnology, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Pertussis Vaccine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Whole-cell Vaccines
Acellular Vaccines
Market segment by Application
12 Months Below
12 Months Above
Major players covered
Sanofi Pasteur
GSK
Mitsubishi Tanabe Pharma
Wuhan Institute of Biological Products
Walvax Biotechnology
Minhai Biotechnology
KM Biologics
Chengdu Institute of Biological Products
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Pertussis Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Pertussis Vaccine, with price, sales, revenue and global market share of Pertussis Vaccine from 2018 to 2023.
Chapter 3, the Pertussis Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pertussis Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Pertussis Vaccine market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Pertussis Vaccine.
Chapter 14 and 15, to describe Pertussis Vaccine sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope of Pertussis Vaccine
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Pertussis Vaccine Consumption Value by Type: 2018 Versus 2022 Versus 2029
- 1.3.2 Whole-cell Vaccines
- 1.3.3 Acellular Vaccines
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Pertussis Vaccine Consumption Value by Application: 2018 Versus 2022 Versus 2029
- 1.4.2 12 Months Below
- 1.4.3 12 Months Above
- 1.5 Global Pertussis Vaccine Market Size & Forecast
- 1.5.1 Global Pertussis Vaccine Consumption Value (2018 & 2022 & 2029)
- 1.5.2 Global Pertussis Vaccine Sales Quantity (2018-2029)
- 1.5.3 Global Pertussis Vaccine Average Price (2018-2029)
2 Manufacturers Profiles
- 2.1 Sanofi Pasteur
- 2.1.1 Sanofi Pasteur Details
- 2.1.2 Sanofi Pasteur Major Business
- 2.1.3 Sanofi Pasteur Pertussis Vaccine Product and Services
- 2.1.4 Sanofi Pasteur Pertussis Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.1.5 Sanofi Pasteur Recent Developments/Updates
- 2.2 GSK
- 2.2.1 GSK Details
- 2.2.2 GSK Major Business
- 2.2.3 GSK Pertussis Vaccine Product and Services
- 2.2.4 GSK Pertussis Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.2.5 GSK Recent Developments/Updates
- 2.3 Mitsubishi Tanabe Pharma
- 2.3.1 Mitsubishi Tanabe Pharma Details
- 2.3.2 Mitsubishi Tanabe Pharma Major Business
- 2.3.3 Mitsubishi Tanabe Pharma Pertussis Vaccine Product and Services
- 2.3.4 Mitsubishi Tanabe Pharma Pertussis Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.3.5 Mitsubishi Tanabe Pharma Recent Developments/Updates
- 2.4 Wuhan Institute of Biological Products
- 2.4.1 Wuhan Institute of Biological Products Details
- 2.4.2 Wuhan Institute of Biological Products Major Business
- 2.4.3 Wuhan Institute of Biological Products Pertussis Vaccine Product and Services
- 2.4.4 Wuhan Institute of Biological Products Pertussis Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.4.5 Wuhan Institute of Biological Products Recent Developments/Updates
- 2.5 Walvax Biotechnology
- 2.5.1 Walvax Biotechnology Details
- 2.5.2 Walvax Biotechnology Major Business
- 2.5.3 Walvax Biotechnology Pertussis Vaccine Product and Services
- 2.5.4 Walvax Biotechnology Pertussis Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.5.5 Walvax Biotechnology Recent Developments/Updates
- 2.6 Minhai Biotechnology
- 2.6.1 Minhai Biotechnology Details
- 2.6.2 Minhai Biotechnology Major Business
- 2.6.3 Minhai Biotechnology Pertussis Vaccine Product and Services
- 2.6.4 Minhai Biotechnology Pertussis Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.6.5 Minhai Biotechnology Recent Developments/Updates
- 2.7 KM Biologics
- 2.7.1 KM Biologics Details
- 2.7.2 KM Biologics Major Business
- 2.7.3 KM Biologics Pertussis Vaccine Product and Services
- 2.7.4 KM Biologics Pertussis Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.7.5 KM Biologics Recent Developments/Updates
- 2.8 Chengdu Institute of Biological Products
- 2.8.1 Chengdu Institute of Biological Products Details
- 2.8.2 Chengdu Institute of Biological Products Major Business
- 2.8.3 Chengdu Institute of Biological Products Pertussis Vaccine Product and Services
- 2.8.4 Chengdu Institute of Biological Products Pertussis Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.8.5 Chengdu Institute of Biological Products Recent Developments/Updates
3 Competitive Environment: Pertussis Vaccine by Manufacturer
- 3.1 Global Pertussis Vaccine Sales Quantity by Manufacturer (2018-2023)
- 3.2 Global Pertussis Vaccine Revenue by Manufacturer (2018-2023)
- 3.3 Global Pertussis Vaccine Average Price by Manufacturer (2018-2023)
- 3.4 Market Share Analysis (2022)
- 3.4.1 Producer Shipments of Pertussis Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
- 3.4.2 Top 3 Pertussis Vaccine Manufacturer Market Share in 2022
- 3.4.2 Top 6 Pertussis Vaccine Manufacturer Market Share in 2022
- 3.5 Pertussis Vaccine Market: Overall Company Footprint Analysis
- 3.5.1 Pertussis Vaccine Market: Region Footprint
- 3.5.2 Pertussis Vaccine Market: Company Product Type Footprint
- 3.5.3 Pertussis Vaccine Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Pertussis Vaccine Market Size by Region
- 4.1.1 Global Pertussis Vaccine Sales Quantity by Region (2018-2029)
- 4.1.2 Global Pertussis Vaccine Consumption Value by Region (2018-2029)
- 4.1.3 Global Pertussis Vaccine Average Price by Region (2018-2029)
- 4.2 North America Pertussis Vaccine Consumption Value (2018-2029)
- 4.3 Europe Pertussis Vaccine Consumption Value (2018-2029)
- 4.4 Asia-Pacific Pertussis Vaccine Consumption Value (2018-2029)
- 4.5 South America Pertussis Vaccine Consumption Value (2018-2029)
- 4.6 Middle East and Africa Pertussis Vaccine Consumption Value (2018-2029)
5 Market Segment by Type
- 5.1 Global Pertussis Vaccine Sales Quantity by Type (2018-2029)
- 5.2 Global Pertussis Vaccine Consumption Value by Type (2018-2029)
- 5.3 Global Pertussis Vaccine Average Price by Type (2018-2029)
6 Market Segment by Application
- 6.1 Global Pertussis Vaccine Sales Quantity by Application (2018-2029)
- 6.2 Global Pertussis Vaccine Consumption Value by Application (2018-2029)
- 6.3 Global Pertussis Vaccine Average Price by Application (2018-2029)
7 North America
- 7.1 North America Pertussis Vaccine Sales Quantity by Type (2018-2029)
- 7.2 North America Pertussis Vaccine Sales Quantity by Application (2018-2029)
- 7.3 North America Pertussis Vaccine Market Size by Country
- 7.3.1 North America Pertussis Vaccine Sales Quantity by Country (2018-2029)
- 7.3.2 North America Pertussis Vaccine Consumption Value by Country (2018-2029)
- 7.3.3 United States Market Size and Forecast (2018-2029)
- 7.3.4 Canada Market Size and Forecast (2018-2029)
- 7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
- 8.1 Europe Pertussis Vaccine Sales Quantity by Type (2018-2029)
- 8.2 Europe Pertussis Vaccine Sales Quantity by Application (2018-2029)
- 8.3 Europe Pertussis Vaccine Market Size by Country
- 8.3.1 Europe Pertussis Vaccine Sales Quantity by Country (2018-2029)
- 8.3.2 Europe Pertussis Vaccine Consumption Value by Country (2018-2029)
- 8.3.3 Germany Market Size and Forecast (2018-2029)
- 8.3.4 France Market Size and Forecast (2018-2029)
- 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
- 8.3.6 Russia Market Size and Forecast (2018-2029)
- 8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
- 9.1 Asia-Pacific Pertussis Vaccine Sales Quantity by Type (2018-2029)
- 9.2 Asia-Pacific Pertussis Vaccine Sales Quantity by Application (2018-2029)
- 9.3 Asia-Pacific Pertussis Vaccine Market Size by Region
- 9.3.1 Asia-Pacific Pertussis Vaccine Sales Quantity by Region (2018-2029)
- 9.3.2 Asia-Pacific Pertussis Vaccine Consumption Value by Region (2018-2029)
- 9.3.3 China Market Size and Forecast (2018-2029)
- 9.3.4 Japan Market Size and Forecast (2018-2029)
- 9.3.5 Korea Market Size and Forecast (2018-2029)
- 9.3.6 India Market Size and Forecast (2018-2029)
- 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
- 9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
- 10.1 South America Pertussis Vaccine Sales Quantity by Type (2018-2029)
- 10.2 South America Pertussis Vaccine Sales Quantity by Application (2018-2029)
- 10.3 South America Pertussis Vaccine Market Size by Country
- 10.3.1 South America Pertussis Vaccine Sales Quantity by Country (2018-2029)
- 10.3.2 South America Pertussis Vaccine Consumption Value by Country (2018-2029)
- 10.3.3 Brazil Market Size and Forecast (2018-2029)
- 10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
- 11.1 Middle East & Africa Pertussis Vaccine Sales Quantity by Type (2018-2029)
- 11.2 Middle East & Africa Pertussis Vaccine Sales Quantity by Application (2018-2029)
- 11.3 Middle East & Africa Pertussis Vaccine Market Size by Country
- 11.3.1 Middle East & Africa Pertussis Vaccine Sales Quantity by Country (2018-2029)
- 11.3.2 Middle East & Africa Pertussis Vaccine Consumption Value by Country (2018-2029)
- 11.3.3 Turkey Market Size and Forecast (2018-2029)
- 11.3.4 Egypt Market Size and Forecast (2018-2029)
- 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
- 11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
- 12.1 Pertussis Vaccine Market Drivers
- 12.2 Pertussis Vaccine Market Restraints
- 12.3 Pertussis Vaccine Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
- 12.5 Influence of COVID-19 and Russia-Ukraine War
- 12.5.1 Influence of COVID-19
- 12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
- 13.1 Raw Material of Pertussis Vaccine and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Pertussis Vaccine
- 13.3 Pertussis Vaccine Production Process
- 13.4 Pertussis Vaccine Industrial Chain
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Pertussis Vaccine Typical Distributors
- 14.3 Pertussis Vaccine Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Pertussis Vaccine . Industry analysis & Market Report on Pertussis Vaccine is a syndicated market report, published as Global Pertussis Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Pertussis Vaccine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
